Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 5
2011 1
2012 9
2013 11
2014 10
2015 14
2016 5
2018 2
2019 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 27069150

51 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic complications with the use of mTOR inhibitors for cancer therapy.
Sivendran S, Agarwal N, Gartrell B, Ying J, Boucher KM, Choueiri TK, Sonpavde G, Oh WK, Galsky MD. Sivendran S, et al. Cancer Treat Rev. 2014 Feb;40(1):190-6. doi: 10.1016/j.ctrv.2013.04.005. Epub 2013 May 16. Cancer Treat Rev. 2014. PMID: 23684373 Free PMC article. Review.
Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials.
Ghatalia P, Je Y, Nguyen PL, Trinh QD, Choueiri TK, Sonpavde G. Ghatalia P, et al. Crit Rev Oncol Hematol. 2015 Aug;95(2):251-63. doi: 10.1016/j.critrevonc.2015.03.006. Epub 2015 Apr 9. Crit Rev Oncol Hematol. 2015. PMID: 25900071 Review.
Adverse events associated with mTOR inhibitors.
Pallet N, Legendre C. Pallet N, et al. Expert Opin Drug Saf. 2013 Mar;12(2):177-86. doi: 10.1517/14740338.2013.752814. Epub 2012 Dec 20. Expert Opin Drug Saf. 2013. PMID: 23252795 Review.
51 results